For research use only.
Verified Samples |
Verified Samples in IHC: Human liver cancer |
Dilution | IHC 1:50-1:300 |
Clonality | Polyclonal |
Immunogen | Fusion protein of human GALNT12 |
Abbre | GALNT12 |
Synonyms | CRCS1, Colorectal cancer susceptibility to 1, FLJ21212, GALNT 12, GLT12, GalNAc T12, GalNAc-T12, GalNAcT12, Galnt12, Polypeptide GalNAc transferase 12, Polypeptide N acetylgalactosaminyltransferase 12, Polypeptide N-acetylgalactosaminyltransferase 12, p, pp GaNTase 12 |
Swissprot | |
Cellular Localization | Golgi apparatus membrane. |
Concentration | 1.26 mg/mL |
Buffer | PBS with 0.05% NaN3 and 40% Glycerol,pH7.4 |
Purification Method | Antigen affinity purification |
Research Areas | Tags, Cell Markers |
Conjugation | Unconjugated |
Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
Shipping | The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended. |
background | This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.:{{item.cat}}
{{index}} {{goods_show_value}}
-
{{item.title}}
IF:{{item.impact}}
Journal:{{item.journal}}
DOI:{{item.doi}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
{{item.content}}